The Agreements provide that effective as of, and contingent on, the closing of the Merger, the executives’ employment agreements will be terminated, and the executives will not be entitled to any further payments thereunder.
Departed
Peter A. Gray
Other Named Officer
ESSA Bancorp, Inc.
Filed
January 10, 2025, 6:59 PM ET
The Agreements provide that effective as of, and contingent on, the closing of the Merger, the executives’ employment agreements will be terminated, and the executives will not be entitled to any further payments thereunder.
Departed
Tamara L. Schock
Executive Vice President and Chief Accounting Officer
On January 7, 2025, Tamara L. Schock, Executive Vice President and Chief Accounting Officer of MetLife, Inc. (the “Company”), informed the Company that she would resign from her position to pursue another opportunity.
Departed
Christian S. Schade
Chair
Omega Therapeutics, Inc.
Effective
2025-01-10
Filed
January 10, 2025, 6:59 PM ET
On January 10, 2025, Christian S. Schade submitted his resignation as Chair and a member of the Board of Directors (the “Board”) of Omega Therapeutics, Inc. (the “Company”), and as a member of the Nominating and Corporate Governance and Compensation Committees of the Board, effective immediately.
On January 7, 2025, Richard Rosenblum provided written notice to the board of directors (the "Board") of Innovative Payment Solutions, Inc., a Nevada corporation (the "Company"), of his resignation as President, Chief Financial Officer, Secretary, and as a member of the Board, effective immediately.
William J. Febbo stepped down from his positions as Chief Executive Officer (“CEO”) and Member of the Board of Directors (the “Board”) of OptimizeRx Corporation (the “Company”) effective as of December 31, 2024.
Departed
Manuel Iglesias
President and Chief Financial Officer
Healthtech Solutions, Inc./UT
Effective
2024-12-20
Filed
January 10, 2025, 6:59 PM ET
On December 20, 2024, the board of directors of Healthtech Solutions, Inc. (the “Company”) removed Manuel Iglesias as the Company’s President and Chief Financial Officer
On January 3, 2025, Robbin B. Adams resigned from his position as Senior Vice President of Geospace Technologies Corporation (the “Company”) in order to pursue other interests.
On January 6, 2025, Michael A. Havard a member of the Board of Directors of Stellar Bancorp, Inc. (the “Company”) provided notice of his decision to not stand for reelection at the Company’s 2025 Annual Shareholder’s Meeting
On January 7, 2025, Mr. Konstantin Anatolyevich Sokolov tendered his resignation as a director of Metal Sky Star Acquisition Corporation (the "Company"), effective on the same date.
On January 5, 2025, Ms. Tianfeng Li, the Chief Financial Officer of Aixin Life International, Inc. (the “Company”), tendered her resignation as Chief Financial Officer of the Company, effective January 5, 2025.
On January 3, 2025, Dorothy Clarke submitted her resignation from the Board of Directors (the “ Board ”) of the Company, effective at 11:59 p.m. Eastern Time on January 6, 2025.
On January 6, 2025, Jesse Deutsch notified American Battery Technology Company (the “Company”) of his intent to retire and step down as Chief Financial Officer, effective January 31, 2025
Departed
Melinda Marchesi
Chief Marketing Officer
PROSPER MARKETPLACE, INC
Effective
2025-01-15
Filed
January 10, 2025, 6:59 PM ET
On January 6, 2025, Melinda Marchesi and Jeff Killian each departed as the Chief Marketing Officer and Executive Vice President of Operations, respectively, of Prosper Marketplace, Inc., effective January 15, 2025.
Departed
Jeff Killian
Executive Vice President of Operations
PROSPER MARKETPLACE, INC
Effective
2025-01-15
Filed
January 10, 2025, 6:59 PM ET
On January 6, 2025, Melinda Marchesi and Jeff Killian each departed as the Chief Marketing Officer and Executive Vice President of Operations, respectively, of Prosper Marketplace, Inc., effective January 15, 2025.
Departed
Susan Smith
Senior Vice President and Chief Commercial Officer
Y-mAbs Therapeutics, Inc.
Effective
2025-04-09
Filed
January 10, 2025, 6:59 PM ET
Susan Smith, the Company’s Senior Vice President and Chief Commercial Officer, will be departing from the Company on April 9, 2025.
On January 3, 2025, David H.Y. Ho, a member of the Board of Directors (the “Board”) of Qorvo, Inc. (the “Company”) informed the Company of his decision not to stand for reelection and to retire from the Board upon the expiration of his term at the Company’s 2025 Annual Meeting of Stockholders.
On January 8, 2025, Jonathon D. Kosoff, Chief Digital Officer of Tilly's, Inc. (the "Company"), notified the Company of his intent to resign from his current role with the Company effective January 24, 2025, to purse another opportunity.
On January 3, 2025, Timothy Hendricks separated from service as Executive Vice President of Sales of Sanuwave Health, Inc. (the “ Company ”), effective as of the same date.
On January 3, 2025, JELD-WEN Holding, Inc. (the “Company”) entered into a Separation and Release Agreement with Kevin Lilly, Executive Vice President, Global Transformation, in connection with his previously announced decision to retire from the Company on such date.
On January 8, 2025, Mr. Michael Bingle notified the Board of Directors of the Company of his resignation from service as a director of the Company, effective January 13, 2025.
On January 8, 2025, Rebecca Boll, Senior Vice President and Chief Product Officer of Fluence Energy, Inc. (the "Company") notified the Company of her intent to resign from all positions with the Company, effective January 31, 2025, to pursue other opportunities.
On January 6, 2025, Bhavesh (Bob) V. Patel notified the Board of Directors that he has decided to not stand for re-election as a Director of Halliburton Company and retire early from serving as a Director of Halliburton Company to pursue other opportunities.
On January 6, 2025, consistent with the foregoing, Mr. Roedel informed the Company of his resignation from the Company’s Board of Directors, effective immediately.
On January 3, 2025, Juan C. Andrade, President and Chief Executive Officer and director of Everest Group, Ltd. (“Everest”) notified Everest that he was resigning to pursue another opportunity.
Departed
Tracey Patterson
Senior Vice President and Chief Human Resources Officer
On January 3, 2025, Tracey Patterson notified AAR CORP. (the “Company”) that she has accepted another professional opportunity outside of the Company and the aviation industry. She will depart from her current position as Senior Vice President and Chief Human Resources Officer and as an employee of the Company effective January 10, 2025 to allow for the appropriate transition.
On January 3, 2025, Amy Lessinger, President of RE/MAX, LLC, a subsidiary of RE/MAX Holdings, Inc. (the “Company”), informed the Company of her resignation from her position, effective January 17, 2025.
Farmers & Merchants Bancorp announced today that Calvin (“Kelly”) Suess, the Company’s longest serving current member of the Board of Directors, has tendered his resignation effective at the next Board of Directors Meeting to be held on January 14, 2025 after having served on the board for 35 years.
Departed
Jeh C. Johnson
Director
UNITED STATES STEEL CORP
Effective
2025-01-07
Filed
January 8, 2025, 6:59 PM ET
On January 7, 2025, Jeh C. Johnson notified United States Steel Corporation (the “Company”) that he was resigning from the Company’s Board of Directors, effective immediately.
QCR Holdings, Inc. (the “Company”) previously announced on May 20, 2024, that John H. Anderson would retire from his roles as Chief Deposit Officer for the Company and as Chief Executive Officer for the Company’s wholly-owned bank subsidiary, Quad City Bank and Trust Company (“QCBT”), effective January 3, 2025 (the “Retirement”).
Departed
Joseph Ramalho
Chief Operating Officer
CLS Holdings USA, Inc.
Effective
2024-12-17
Filed
January 8, 2025, 6:59 PM ET
On December 17, 2024, CLS Holdings USA, Inc. (the “Company”) terminated the employment of Joseph Ramalho, its Chief Operating Officer.
Departed
John Schmid
Director
Poseida Therapeutics, Inc.
Effective
2025-01-08
Filed
January 8, 2025, 6:59 PM ET
each of Rafael Amado, Charles Baum, Cynthia Collins, Luke Corning, Mark Gergen, Marcea Lloyd, John Schmid and Kristin Yarema voluntarily resigned as directors of the Company
Departed
Mark Gergen
Other Named Officer
Poseida Therapeutics, Inc.
Effective
2025-01-08
Filed
January 8, 2025, 6:59 PM ET
Mark Gergen resigned as an officer and separated from employment with the Company effective as of immediately following the Effective Time
Departed
Rafael Amado
Director
Poseida Therapeutics, Inc.
Effective
2025-01-08
Filed
January 8, 2025, 6:59 PM ET
each of Rafael Amado, Charles Baum, Cynthia Collins, Luke Corning, Mark Gergen, Marcea Lloyd, John Schmid and Kristin Yarema voluntarily resigned as directors of the Company
Departed
Marcea Lloyd
Director
Poseida Therapeutics, Inc.
Effective
2025-01-08
Filed
January 8, 2025, 6:59 PM ET
each of Rafael Amado, Charles Baum, Cynthia Collins, Luke Corning, Mark Gergen, Marcea Lloyd, John Schmid and Kristin Yarema voluntarily resigned as directors of the Company
Departed
Luke Corning
Director
Poseida Therapeutics, Inc.
Effective
2025-01-08
Filed
January 8, 2025, 6:59 PM ET
each of Rafael Amado, Charles Baum, Cynthia Collins, Luke Corning, Mark Gergen, Marcea Lloyd, John Schmid and Kristin Yarema voluntarily resigned as directors of the Company
Departed
Mark Gergen
Director
Poseida Therapeutics, Inc.
Effective
2025-01-08
Filed
January 8, 2025, 6:59 PM ET
each of Rafael Amado, Charles Baum, Cynthia Collins, Luke Corning, Mark Gergen, Marcea Lloyd, John Schmid and Kristin Yarema voluntarily resigned as directors of the Company
Departed
Cynthia Collins
Director
Poseida Therapeutics, Inc.
Effective
2025-01-08
Filed
January 8, 2025, 6:59 PM ET
each of Rafael Amado, Charles Baum, Cynthia Collins, Luke Corning, Mark Gergen, Marcea Lloyd, John Schmid and Kristin Yarema voluntarily resigned as directors of the Company
Departed
Kristin Yarema
Director
Poseida Therapeutics, Inc.
Effective
2025-01-08
Filed
January 8, 2025, 6:59 PM ET
each of Rafael Amado, Charles Baum, Cynthia Collins, Luke Corning, Mark Gergen, Marcea Lloyd, John Schmid and Kristin Yarema voluntarily resigned as directors of the Company
Departed
Charles Baum
Director
Poseida Therapeutics, Inc.
Effective
2025-01-08
Filed
January 8, 2025, 6:59 PM ET
each of Rafael Amado, Charles Baum, Cynthia Collins, Luke Corning, Mark Gergen, Marcea Lloyd, John Schmid and Kristin Yarema voluntarily resigned as directors of the Company
Departed
Catherine Keating
Senior Executive Vice President and Global Head of Wealth Management
On January 7, 2025, Catherine Keating, Senior Executive Vice President and Global Head of Wealth Management of The Bank of New York Mellon Corporation (the “Company”) and a Named Executive Officer of the Company, informed the Company she will be retiring from the Company effective April 30, 2025.
On January 2, 2025, Ford Tamer notified the Board of Directors (the “Board”) of Teradyne, Inc. (“Teradyne”) of his decision not to stand for re-election at Teradyne’s next annual meeting of shareholders, expected to be held in May 2025
Also on January 6, 2025, Wong Kok Seong and Doris Wong Sing Ee each resigned from their positions as Independent Director of the Company, effective immediately.
Also on January 6, 2025, Wong Kok Seong and Doris Wong Sing Ee each resigned from their positions as Independent Director of the Company, effective immediately.
The terms of Beth H. Harwell and Brian E. Noland as members of the Tennessee Valley Authority ("TVA") Board of Directors ended January 3, 2025, with the adjournment of the most recent session of Congress.
Recent executive movements from 8-K Item 5.02 filings, source-linked. Cards are extracted by an LLM and gated to those whose source quote is present verbatim in the filing text. Coverage is best-effort while backfill and monitoring mature; this is not yet a full-market index. See methodology.